Currently submitted to: JMIR Human Factors
Date Submitted: May 8, 2026
Open Peer Review Period: May 11, 2026 - Jul 6, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Enabling interdisciplinary integration in early-stage biotech consortia: a generative co-design approach using the business model canvas
ABSTRACT
Background:
Multidisciplinary science programs tackling grand societal challenges often lack effective innovation strategies, particularly towards an integrated application idea.
Objective:
This study describes how to move from monodisciplinary research lines in early-stage biotech research consortia towards an interdisciplinary convergence research strategy.
Methods:
We conceptualise the research process as an innovation process and explore how different researchers can integrate their ideas through generative co-design (GCD) tools and the Business Model Canvas. Empirical data were gathered from three workshops, a consortium discussion, and two surveys within a large multidisciplinary biotech consortium. Our analysis focused on social interaction, drawing on both individuals' tacit and explicit knowledge.
Results:
Minimum feasible products, as opposed to minimum viable products, developed in GCD workshops facilitated the collaboration across disciplines and integrated knowledge across topics.
Conclusions:
The study offers theoretical contributions for researchers and practical insights for funding bodies aiming to enhance the impact of early-phase biotech research.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.